FII Prothrombin Kit
£244.00
The geneMAP™ FII Prothrombin Kit is designed for the detection of genetic risk factors associated with thrombophilia, particularly focusing on Prothrombin/Factor II G20210A mutations and their correlation with elevated thrombosis risk, especially when combined with FV Leiden mutations. Utilizing multiplex RT-PCR technology, these kits simplify the process of identifying key mutations implicated in abnormal blood coagulation and thrombosis.
- Ready to Reaction Mix: Simplifies preparation and reduces potential errors, facilitating ease of use.
- Accurate Results: Includes controls for both homozygous and heterozygous conditions to ensure result reliability.
- Dual Color Compatibility: Designed for use with real-time PCR instruments that detect FAM and VIC/HEX, allowing for simultaneous detection of multiple targets.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, ensuring quality and reliability.
Detection of Thrombophilia Genetic Risk Factors: Specifically tailored for the simultaneous detection of Prothrombin/Factor II G20210A and other relevant mutations that contribute to an increased risk of thrombosis. This is crucial for identifying individuals at risk for venous thrombosis and related conditions, such as pulmonary embolism.
- Technology: Multiplex RT-PCR for the detection of key genetic mutations associated with thrombophilia.
- Compatibility: Suitable for use with FAM and VIC/HEX dual-color real-time PCR instruments.
- Included Controls: Homozygous and heterozygous controls to validate assay accuracy.
- Certification: CE-IVD marked, indicating regulatory compliance within the European Union for in vitro diagnostic use.
- Ready to Reaction Mix: Simplifies preparation and reduces potential errors, facilitating ease of use.
- Accurate Results: Includes controls for both homozygous and heterozygous conditions to ensure result reliability.
- Dual Color Compatibility: Designed for use with real-time PCR instruments that detect FAM and VIC/HEX, allowing for simultaneous detection of multiple targets.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, ensuring quality and reliability.
Detection of Thrombophilia Genetic Risk Factors: Specifically tailored for the simultaneous detection of Prothrombin/Factor II G20210A and other relevant mutations that contribute to an increased risk of thrombosis. This is crucial for identifying individuals at risk for venous thrombosis and related conditions, such as pulmonary embolism.
- Technology: Multiplex RT-PCR for the detection of key genetic mutations associated with thrombophilia.
- Compatibility: Suitable for use with FAM and VIC/HEX dual-color real-time PCR instruments.
- Included Controls: Homozygous and heterozygous controls to validate assay accuracy.
- Certification: CE-IVD marked, indicating regulatory compliance within the European Union for in vitro diagnostic use.
Why Choose Clent
We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.
